Results 101 to 110 of about 49,394 (216)
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [PDF]
The manuscript was reviewed by Jo’s Trust, which supports the conclusions. It made the following statement: We think (it has) massive implications for the screening programme, vaccine and also impact on diagnoses in the future.
Cruickshank, Margaret +6 more
core +4 more sources
The review provides a comprehensive analysis of microbiome‐mediated oncogenic mechanisms in various cancers, emphasizing the unique therapeutic strategies facilitated by nanotechnology. It aims to fill this gap by systematically reviewing nanotechnology‐driven strategies for microbiome elimination, with a focus on their ability to improve the cold TME ...
Yumei Gan, Yan Zhang, Xia Dong, Feng Lv
wiley +1 more source
New options for early diagnosis and prevention of HPV-associated cervical lesions
The review examines the relationship of human papillomavirus and its role in cervical intraepithelial neoplasia (CIN) and cervical cancer. The most informative methods of diagnostics (immunohistochemical, molecular-genetic and other) and treatment of HPV-
V. N. Prilepskaya +4 more
doaj +1 more source
Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. [PDF]
ObjectiveA biomarker with increased specificity for cervical dysplasia compared with human papillomavirus (HPV) testing would be an attractive option for cervical cancer screening among HIV-infected women in resource-limited settings. p16(INK4a) has been
Huchko, Megan J +5 more
core +1 more source
Ageing acts as a double‐edged sword in cancer. In the elderly, open chromatin, immunosenescence, and chronic inflammation drive SASP (IL‐6, MMPs), MDSC accumulation and T‐cell suppression, fostering tumor‐promoting microenvironments and limited therapeutic benefit.
Qi Wang +7 more
wiley +1 more source
Abstract HPV vaccination reduces the risk of developing HPV‐attributable cancers, including cervical cancer. However, an attenuation of HPV vaccine impact after the implementation of HPV vaccination may occur through clinical unmasking. Clinical unmasking is a distinct and complex phenomenon that arises in the absence of clinical interventions ...
Joseph E. Tota +8 more
wiley +1 more source
Results of loop diathermy conization as diagnostic and therapeutic procedure
Introduction: currently broadcasts the use of diathermy handles for the treatment of premalignant lesions of the neck. Objective: to present the results of loop diathermy conization in cervical premalignant lesions.
Yarima Bravo Torres +5 more
doaj
Human papillomavirus genotyping among the women with cervical abnormalities in Ulaanbaatar, Mongolia [PDF]
学位記番号 ...
TSEDENBAL, BATCHIMEG +2 more
core
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance : systematic review and meta-analysis [PDF]
OBJECTIVE To estimate the regression, persistence, and progression of untreated cervical intraepithelial neoplasia grade 2 (CIN2) lesions managed conservatively as well as compliance with follow-up protocols.
Aaltonen, R +16 more
core +3 more sources
What's new? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo +6 more
wiley +1 more source

